These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2125250)

  • 1. Bone marrow transplantation in canine GM1 gangliosidosis.
    O'Brien JS; Storb R; Raff RF; Harding J; Appelbaum F; Morimoto S; Kishimoto Y; Graham T; Ahern-Rindell A; O'Brien SL
    Clin Genet; 1990 Oct; 38(4):274-80. PubMed ID: 2125250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal-visceral GM1 gangliosidosis in a dog with beta-galactosidase deficiency.
    Read DH; Harrington DD; Keenana TW; Hinsman EJ
    Science; 1976 Oct; 194(4263):442-5. PubMed ID: 824730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM1 gangliosidosis in Portuguese water dogs: pathologic and biochemical findings.
    Saunders GK; Wood PA; Myers RK; Shell LG; Carithers R
    Vet Pathol; 1988 Jul; 25(4):265-9. PubMed ID: 3136586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine GM1 gangliosidosis. An ultrastructural and biochemical study.
    Rodriguez M; O'Brien JS; Garrett RS; Powell HC
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):618-29. PubMed ID: 6813429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM1 gangliosidosis: phenotypic variation in a single family.
    Farrell DF; Ochs U
    Ann Neurol; 1981 Mar; 9(3):225-31. PubMed ID: 6784662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
    Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y
    J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of human beta-galactosidase in GM1-gangliosidosis and Morquio B syndrome.
    Hoogeveen AT; Graham-Kawashima H; d'Azzo A; Galjaard H
    J Biol Chem; 1984 Feb; 259(3):1974-7. PubMed ID: 6420416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of type 2 Gm1-gangliosidosis with long survival.
    Kikuchi K; Minami R; Kudoh T; Nakao T; Tsugawa S
    Brain Dev; 1982; 4(2):153-6. PubMed ID: 6807121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine GM1-gangliosidosis. A clinical, morphologic, histochemical, and biochemical comparison of two different models.
    Alroy J; Orgad U; DeGasperi R; Richard R; Warren CD; Knowles K; Thalhammer JG; Raghavan SS
    Am J Pathol; 1992 Mar; 140(3):675-89. PubMed ID: 1546746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 3 (chronic) GM1 gangliosidosis presenting as infanto-choreo-athetotic dementia, without epilepsy, in three sisters.
    Guazzi GC; D'Amore I; Van Hoof F; Fruschelli C; Alessandrini C; Palmeri S; Federico A
    Neurology; 1988 Jul; 38(7):1124-7. PubMed ID: 3133574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis.
    Shield JP; Stone J; Steward CG
    J Inherit Metab Dis; 2005; 28(5):797-8. PubMed ID: 16151914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lysosomal beta-galactosidase properties and the molecular genetics of GM1 gangliosidosis].
    Vel'tishchev IuE; Kalaidzhieva LV
    Vopr Med Khim; 1979; 25(6):709-15. PubMed ID: 117628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GM1 gangliosidosis, type I, Landing's disease. Presentation of a case and review of the literature].
    Alonso Falcón F; López-Herce J
    An Esp Pediatr; 1984 Feb; 20(2):139-45. PubMed ID: 6424522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The abnormalities of beta-galactosidase in GM1-gangliosidoses.
    Kudoh T
    Tohoku J Exp Med; 1978 May; 125(1):93-101. PubMed ID: 27879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal-visceral GM1 gangliosidosis in Portuguese water dogs.
    Shell LG; Potthoff AI; Carithers R; Katherman A; Saunders GK; Wood PA; Giger U
    J Vet Intern Med; 1989; 3(1):1-7. PubMed ID: 2494322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurovisceral and skeletal GM1-gangliosidosis in dogs with beta-galactosidase deficiency.
    Alroy J; Orgad U; Ucci AA; Schelling SH; Schunk KL; Warren CD; Raghavan SS; Kolodny EH
    Science; 1985 Aug; 229(4712):470-2. PubMed ID: 3925555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1 gangliosidosis: enzymatic variation in a single family.
    Farrell DF; MacMartin MP
    Ann Neurol; 1981 Mar; 9(3):232-6. PubMed ID: 6784663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a GM1 ganglioside beta-galactosidase microassay method to diagnosis of GM1 gangliosidosis.
    Mutoh T; Kiuchi K; Sobue I; Naoi M
    Clin Chim Acta; 1984 Jul; 140(3):223-30. PubMed ID: 6432371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
    Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
    Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.
    Kohyama M; Yabuki A; Ochiai K; Nakamoto Y; Uchida K; Hasegawa D; Takahashi K; Kawaguchi H; Tsuboi M; Yamato O
    BMC Vet Res; 2016 Mar; 12():67. PubMed ID: 27036194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.